A live webcast of the presentation will be available under "Webcasts" in the Investors section of www.thresholdpharm.com. A replay of the presentation will be archived on the site for 30 days.
Except for statements of historical fact, the statements in this press release are forward-looking statements, including statements regarding the potential therapeutic uses and benefits of its drug candidates. These statements involve risks and uncertainties that can cause actual results to differ materially from those in
such forward-looking statements. Potential risks and uncertainties include, but are not limited to: Threshold's need for and the availability of resources to develop its drug candidates and to support Threshold's operations including the expense required to conduct clinical trials and analyze data; issues arising in the regulatory or manufacturing process and the results of such clinical trials (including product safety issues and efficacy results). Further information regarding these and other risks is included under the heading "Risk Factors" in Threshold's Quarterly Report on Form 10-Q, which has been filed with the
Mark Hopkins, Ph.D., J.D. Vice President of Intellectual Property and Assistant General Counsel Phone: 650-474-8213 E-mail: email@example.com
News Provided by Acquire Media